Real World Diagnosis and Treatment Outcomes in Patients with EGFR-Mutant Metastatic Lung Cancer

被引：0
|
作者：
Li, T. [1 ]
Ma, W. [1 ]
Tian, E. [1 ]
Li, Q. [1 ]
机构：
[1] Univ Calif Davis, Comprehens Canc Ctr, Div Hematol Oncol, Internal Med, Sacramento, CA 95817 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
EGFR-mutant lung cancer; treatment outcome; Survival;
D O I：
10.1016/j.jtho.2019.08.2371
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1.16-06
引用
收藏
页码：S1066 / S1067
页数：2
相关论文
共 50 条
  • [1] Does dose reduction of afatinib affect treatment outcomes of patients with EGFR-mutant metastatic non-small cell lung cancer in real-world clinical practice?
    Poh, Mau Ern
    Chai, Chee Shee
    Liam, Chong Kin
    Ho, Gwo Fuang
    Pang, Yong Kek
    Hasbullah, Harissa Husainy
    Tho, Lye Mun
    Nor, Ibtisam Muhamad
    Ho, Kean Fatt
    Thiagarajan, Muthukkumaran
    Samsudin, Azlina
    Omar, Azza
    Ong, Choo Khoon
    Soon, Sing Yang
    Tan, Sin Nee
    How, Soon Hin
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (02) : 307 - 320
  • [2] Clinical Characteristics and Outcomes of Patients with EGFR-mutant Lung Cancer with Acquired BRAF Alterations
    Sui, J.
    Yang, S. R.
    Bowman, A. S.
    Vankayala, P.
    Falcon, C.
    Somwar, R.
    Drilon, A. E.
    Riely, G. J.
    Kris, M. G.
    Ladanyi, M.
    Yu, H. A.
    Offin, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S337 - S337
  • [3] Real-world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer
    Xu, Ting
    Li, Jian
    Wang, Zhenghang
    Zhang, Xiaotian
    Zhou, Jun
    Lu, Zhihao
    Shen, Lin
    Wang, Xicheng
    CANCER MEDICINE, 2023, 12 (09): : 10473 - 10484
  • [4] Real-World Pattern of Treatment and Clinical Outcomes of EGFR-Mutant Non-Small Cell Lung Cancer in a Single Academic Centre in Quebec
    Agulnik, Jason S.
    Kasymjanova, Goulnar
    Pepe, Carmela
    Hurry, Manjusha
    Walton, Ryan N.
    Sakr, Lama
    Cohen, Victor
    Small, David
    CURRENT ONCOLOGY, 2021, 28 (06) : 5179 - 5191
  • [5] Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis
    Chiang, Chi-Lu
    Ho, Hsiang-Ling
    Yeh, Yi-Chen
    Lee, Cheng-Chia
    Huang, Hsu-Ching
    Shen, Chia-, I
    Luo, Yung-Hung
    Chen, Yuh-Min
    Chiu, Chao-Hua
    Chou, Teh-Ying
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (01) : 5 - 14
  • [6] Prognosis of EGFR-mutant advanced lung adenocarcinoma patients with different intrathoracic metastatic patterns
    Hu, Fang
    Zhang, Bo
    Li, Changhui
    Xu, Jianlin
    Wang, Huimin
    Gu, Ping
    Zheng, Xiaoxuan
    Nie, Wei
    Shen, Yinchen
    Zhang, Hai
    Hu, Ping
    Zhang, Xueyan
    JOURNAL OF CANCER, 2019, 10 (05): : 1254 - 1262
  • [7] Impact of Ethnicity on Incidence of Brain Metastasis in Patients with EGFR-Mutant Lung Cancer
    Zhang, Jiexia
    Wen, Huiyu
    Cai, Di
    La, Hahn
    Gandara, David R.
    He, Jianxin
    Qi, Lihong
    Li, Tianhong
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S591 - S591
  • [8] Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors
    Dogan, Izzet
    Khanmammadov, Nijat
    Paksoy, Nail
    Vatansever, Sezai
    Saip, Pinar
    Aydiner, Adnan
    EURASIAN JOURNAL OF PULMONOLOGY, 2023, 25 (01) : 27 - 32
  • [9] Multiple treatment modalities for brain metastasis in patients with EGFR-mutant non-small-cell lung cancer
    Wang, Haiyang
    Yu, Xiaoqing
    Fan, Yun
    Jiang, Youhua
    ONCOTARGETS AND THERAPY, 2018, 11 : 2149 - 2155
  • [10] Impact of Asian ethnicity on outcome in metastatic EGFR-mutant non-small cell lung cancer
    Gibson, Amanda J. W.
    D'Silva, Adrijana
    Elegbede, Anifat A.
    Tudor, Roxana A.
    Dean, Michelle L.
    Bebb, Dafydd Gwyn
    Hao, Desiree
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (06) : 343 - 352
12345